and its engineers were said to view their new 3D printer with suspicion. But, with its latest car, that image of Morgan is changing. The Supersport might look like Morgans of old – and Morgans ...
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $120.00. The company’s shares closed yesterday at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results